<code id='276EF6CA2C'></code><style id='276EF6CA2C'></style>
    • <acronym id='276EF6CA2C'></acronym>
      <center id='276EF6CA2C'><center id='276EF6CA2C'><tfoot id='276EF6CA2C'></tfoot></center><abbr id='276EF6CA2C'><dir id='276EF6CA2C'><tfoot id='276EF6CA2C'></tfoot><noframes id='276EF6CA2C'>

    • <optgroup id='276EF6CA2C'><strike id='276EF6CA2C'><sup id='276EF6CA2C'></sup></strike><code id='276EF6CA2C'></code></optgroup>
        1. <b id='276EF6CA2C'><label id='276EF6CA2C'><select id='276EF6CA2C'><dt id='276EF6CA2C'><span id='276EF6CA2C'></span></dt></select></label></b><u id='276EF6CA2C'></u>
          <i id='276EF6CA2C'><strike id='276EF6CA2C'><tt id='276EF6CA2C'><pre id='276EF6CA2C'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:4
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          PBMs drew scrutiny in House hearing — and so did pharma
          PBMs drew scrutiny in House hearing — and so did pharma

          Rep.JamesComer,chairoftheHouseOversightCommitteeKevinDietsch/GettyImagesWASHINGTON—Congresswantstore

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

          AbbvieCEORichardGonzalezwillstepdowninJuly.JacquelynMartin/APAbbVieannouncedTuesdaythatCEORichardGon